Latest MYOC Stories
Using a novel high-throughput screening process, scientists have for the first time identified molecules with the potential to block the accumulation of a toxic eye protein that can lead to early onset of glaucoma.
Inhibiting the protein, Grp94, could offer new treatment for the sight-robbing eye disease
Glaucoma is the second leading cause of blindness.
By studying a mouse model, researchers have obtained new insights about glaucoma, the second most common cause of blindness in the United States.
An eye under pressure appears to express a unique set of proteins that physicians hope will one day help them better diagnose and treat glaucoma.
- A poem in which the author retracts something said in an earlier poem.